The pharmaceutical industry is buzzing with anticipation for the Global Tech Summit 2023, set to take place in Visakhapatnam from February 16–17. Recently, the Global Tech Summit team, led by Dr. Srinubabu Gedela, CEO of Pulsus Group, held a ground-breaking roadshow and business-to-biopharma digital transformation policy design meetings in Nagpur as part of the 72nd Indian Pharmaceutical Congress.
This historic event brought together 50 influential policymakers, global pharma experts, and other decision-makers to discuss how the Global Tech Summit is becoming a revolutionary platform for the application of cutting-edge technology in drug discovery, regulatory affairs, and making medicine more affordable for all.
During the Round Table Series of Biopharma Digital Transformation Policy Deliberations, participants heard from key figures in the industry about the challenges facing regulators in digital healthcare.
Dr. Dominique Jordan, President of the International Pharmaceutical Federation, highlighted the potential impact of technology in revolutionizing drug discovery. “Digital transformation in the pharmaceutical sector involves implementing various digital technologies to improve the production and provision of healthcare products and services,”.
“The pharmaceutical business may gain from digital transformation in a number of ways, such as better medication research, patient care, and engagement; technology makes medicine more accessible and inexpensive; it lowers carbon footprint; and it increases supply chain transparency. added Dr. Jordan.
The relevance of utilizing digital technologies in drug development, such as artificial intelligence and machine learning, was also covered by the Global Tech Summit team and the presenters. Dr. Atul Nasa, the current president of the Indian Pharma Graduates Association and a previous governing licensure authority, stated that "AI and ML can assist speed drug development by processing massive volumes of data and swiftly and effectively finding new drug candidates."
“Regulators must find a balance between encouraging innovation and protecting public health,” said Dr. H.G. Koshia, Commissioner of Food and Drug Control Administration, Government of Gujarat. Dr. Montkumar M. Patel, President of the Pharmacy Council of India, also spoke at the meeting about some of the challenges facing regulators when it comes to digital healthcare.
Abhijit Ghosh, Assistant Drug Controller at the Medical Device Standards Control Organization, provided his expert opinion on the potential way forward for India. “Digital transformation in the pharmaceutical industry is inevitable, and India should take the lead in developing policies that encourage innovation while protecting public health”.
Both Dr. Alka Mukne, Editor in Chief of Pharma Times, and Dr. T. V. Narayana, President of the Indian Pharmaceutical Association, emphasized the significance of collaboration between the pharmaceutical and academic industries. They claimed that combining the financial support of pharma companies with early-stage drug molecules from academic institutions is a key source of innovation, with many successful assets being developed and commercialized through institutional technology out-licensing.
A participant in the conversation and the current president of the Indian Pharma Graduates Association, Dr. Atul Nasa, voiced his support for the idea of using the Global Tech Summit in 2023 as a forum for the digital transformation of the pharmaceutical business.
Global Tech Summit
Posted on: Feb 13, 2023
